Name: 2-year Outcomes of the BIOSTEMI RCT and its Implications for Clinical Practice
Uploaded: 2021-07-07T15:42:14+01:00
Duration: 7 min 43 s
Description: Dr. Juan F. Iglesias, Co-Principal Investigator of the BIOSTEMI trial, is discussing the 2-year outcomes of the BIOSTEMI RCT, sharing his insight from the trial and its implications to everyday clinical practice.

Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts News Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Deep Vein Thrombosis Empagliflozin in the Treatment of Chronic Heart Failure Pulmonary Embolism Pulsed Field Ablation

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Topics

Content Type

Journals

Faculty

Events

Resource Hubs

Video

2-year Outcomes of the BIOSTEMI RCT and its Implications for Clinical Practice

Published: 07 Jul 2021

Views:
581
Likes:
0

Average (ratings)

No ratings

Your rating

Dr. Juan F. Iglesias, Co-Principal Investigator of the BIOSTEMI trial, is discussing the 2-year outcomes of the BIOSTEMI RCT, sharing his insight from the trial and its implications to everyday clinical practice.

This activity has been supported by Biotronik